Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03973320 · ClinicalTrials.gov registry record
Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty
A clinical trial, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- 11,292
- Enrollment target
NCT03973320: Completed study, sponsored by Hospital for Special Surgery, New York.
NCT03973320 is a clinical trial that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 11,292 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03973320 has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- 11,292 participants
- Enrollment target
Study Summary
This is a retrospective chart review to determine if neuraxial anesthesia is associated with worse outcomes after Primary Total Hip Arthroplasty.
Primary Outcome
The association between levels and length of intraoperative controlled hypotension and incidence rates of individual and composite outcome of any of the following events: (i) myocardial infarction (MI), (ii) cerebrovascular accident (CVA), (iii) death. If any of these events are positive, then the composite outcome will be positive. The units of measurement will be the same.
Interventions
- OTHER Chart Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,292 participants |
| Start Date | 2018-12-27 |
| Est. Completion | 2019-11-18 |
What the finished NCT03973320 record still lists
NCT03973320 is an observational study that tracks outcomes without assigning an intervention. Its 11,292 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Chart Review is the first listed.
NCT03973320 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03973320 about?
NCT03973320 is a clinical study titled "Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty". This is a retrospective chart review to determine if neuraxial anesthesia is associated with worse outcomes after Primary Total Hip Arthroplasty.
What is the current status of trial NCT03973320?
This trial is currently completed. The enrollment target is 11,292 participants. The study started on 2018-12-27. Estimated completion is 2019-11-18.
What interventions are being tested in trial NCT03973320?
The interventions under investigation include: Chart Review (OTHER).
Who is sponsoring clinical trial NCT03973320?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06677060 · 11,300 participants · Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- NCT07181109 · 11,000 participants · Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI